Hot search: New  Auto  plant  Lighting  Brake  Furniture  Accessories  environmental  Parts  modern 
 
Home > News > Market > Content

Avidbiotics Receives Sbir Grant to Develop Proteins to Kill Clostridium Difficile Bacteria

increase font size  reduce font Add date: 2016-11-30  Hits:118
Core prompt: AvidBiotics has received new Small Business Innovation Research (SBIR) grant from the National Institute of Allergic and Infectious Diseases of the National Institutes of Health to f

AvidBiotics has received new Small Business Innovation Research (SBIR) grant from the National Institute of Allergic and Infectious Diseases of the National Institutes of Health to further develop targetable bactericidal proteins to kill Clostridium difficile bacteria. 

As part of the grant, AvidBiotics will receive $600,000 funds spreading over two years.

AvidBiotics chief executive officer David Martin said Clostridium difficile has become the most frequent cause of hospital-acquired infections overtaking methicillin-resistant Staph. Aureus.

"This new funding will help support our preclinical research and advance Avidocin proteins towards the clinic," Martin added.

AvidBiotics' Avidocin antibacterial proteins will kill target organisms without collateral damage to non-targeted bacteria in bacterial health threats.

 

 

 
 
[ NewsSearch ]  [ Send Fav ]  [ Share ]  [ Print ]  [ Send Report ]  [ Close ]

 
Total0bar [View All]  Related Comments

 
Photo Recommended
Recommend News
Click Rank
 
Home | Products | Suppliers | News | Tradeshow | Sitemap | Message | RSS Feed